RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
74 hedge funds and large institutions have $359M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 11 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 20
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
17% more capital invested
Capital invested by funds: $308M → $359M (+$51.7M)
4% more funds holding
Funds holding: 71 → 74 (+3)
9% less call options, than puts
Call options by funds: $19.1M | Put options by funds: $20.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$9.78M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.4M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$3.5M |
| 4 |
Jane Street
New York
|
+$3.38M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Assured Investment Management
New York
|
-$9.89M |
| 2 |
O
OrbiMed
New York
|
-$6M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.08M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.28M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$2.06M |
RPTP Hedge Fund Activity: Q2 2014 in Review
74 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q2 2014, worth a combined $359M — up 17% from $308M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new RPTP positions and 11 closed out — a net gain of 3 holders — while 28 added to existing stakes and 20 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $9.78M. The largest seller was Assured Investment Management, exiting entirely with an estimated $9.89M sold.
- 74 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q2 2014, up from 71 in Q1 2014.
- Funds reported $359M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q2 2014, up 17% quarter-over-quarter.
- 14 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q2 2014 and 11 closed out, a net change of +3 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q2 2014 was Goldman Sachs, an estimated $9.78M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q2 2014 was Assured Investment Management, an estimated $9.89M sold.
Based on aggregated 13F filings for Q2 2014.